Granata Bio's GRACE Study Advances Reproductive Health Solutions in the U.S. Granata Bio is making strides in its Phase III study of an investigational gonadotropin aimed at enhancing assisted reproductive technology in the U.S.

Granata Bio's GRACE Study Advances Reproductive Health Solutions in the U.S. #United_States #Boston #Reproductive_Health #Fertility_Treatment #Granata_Bio

Granata Bio and Georgetown Equity Partners Form Joint Venture for Advancing Next-Generation FSH Development Granata Bio Corporation and Georgetown Equity Partners are teaming up to develop an innovative form of follicle-stimulating hormone for improved reproductive health.

Granata Bio and Georgetown Equity Partners Form Joint Venture for Advancing Next-Generation FSH Development #None #GEP #Granata_Bio #FSH #Boston,_Denver

Granata Bio and Gedeon Richter Join Forces to Strengthen U.S. Fertility Market Granata Bio partners with Gedeon Richter to enhance its U.S. fertility portfolio, focusing on co-development projects and addressing market needs.

Granata Bio and Gedeon Richter Join Forces to Strengthen U.S. Fertility Market #United_States #Boston #Fertility #Granata_Bio #Gedeon_Richter

Granata Bio Strengthens Women's Health with Oviva Therapeutics Acquisition Granata Bio has acquired Oviva Therapeutics, aiming to enhance women's health through innovative treatments focusing on ovarian aging and function.

Granata Bio Strengthens Women's Health with Oviva Therapeutics Acquisition #USA #Boston #Women's_Health #Granata_Bio #Oviva_Therapeutics

Granata Bio Secures $15 Million to Advance Women's Reproductive Health Solutions Granata Bio Corporation has successfully raised $15 million in Series A+ funding to advance its pipeline in women's reproductive health, focusing on infertility solutions.

Granata Bio Secures $15 Million to Advance Women's Reproductive Health Solutions #USA #Boston #Granata_Bio #Gedeon_Richter #CooperSurgical